Primus XL Suspoemulsion Danmark - dansk - SEGES Landbrug & Fødevarer

primus xl suspoemulsion

dow agrosciences danmark a/s - florasulam, fluroxypyr - suspoemulsion - 5 g/l florasulam ; 100 g/l fluroxypyr

Starane XL Suspoemulsion Danmark - dansk - SEGES Landbrug & Fødevarer

starane xl suspoemulsion

dow agrosciences danmark a/s - florasulam, fluroxypyr - suspoemulsion - 2,5 g/l florasulam ; 100 g/l fluroxypyr

Tombo Vanddispergerbart granulat Danmark - dansk - SEGES Landbrug & Fødevarer

tombo vanddispergerbart granulat

dow agrosciences danmark a/s - florasulam, aminopyralid, pyroxsulam - vanddispergerbart granulat - 25 g/kg florasulam ; 50 g/kg aminopyralid ; 50 g/kg pyroxsulam

Zypar OD-formulering Danmark - dansk - SEGES Landbrug & Fødevarer

zypar od-formulering

dow agrosciences danmark a/s - florasulam, halauxifen-methyl, halauxifen, cloquintocet-mexyl, cloquintocet - od-formulering - 5 g/l florasulam ; 6,25 g/l halauxifen-methyl ; (~ 6,00 g/l halauxifen) ; 6,25 g/l cloquintocet-mexyl ; (~ 4,42 g/l cloquintocet)

Rexade 440 Vanddispergerbart granulat Danmark - dansk - SEGES Landbrug & Fødevarer

rexade 440 vanddispergerbart granulat

dow agrosciences danmark a/s - florasulam, pyroxsulam, halauxifen-methyl, halauxifen, cloquintocet-mexyl, cloquintocet - vanddispergerbart granulat - 100 g/kg florasulam ; 240 g/kg pyroxsulam ; 104,2 g/kg halauxifen-methyl ; (~ 100,0 g/kg halauxifen) ; 300,29 g/kg cloquintocet-mexyl ; (~ 212 g/kg cloquintocet)

Clopidogrel Acino Den Europæiske Union - dansk - EMA (European Medicines Agency)

clopidogrel acino

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotiske midler - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.